Amanote Research
Register
Sign In
Nivolumab Plus Ipilimumab Achieves Responses in dMMR/MSI-H Tumors
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-rw2018-017
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
February 2, 2018
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)